Dapagliflozin in Patients with Chronic Kidney Disease. Reply

N Engl J Med. 2021 Jan 28;384(4):389-390. doi: 10.1056/NEJMc2032809.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzhydryl Compounds / adverse effects
  • Glucosides* / therapeutic use
  • Humans
  • Renal Insufficiency, Chronic* / drug therapy

Substances

  • Benzhydryl Compounds
  • Glucosides
  • dapagliflozin